Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Osaze Udeagbala drives clinical science efforts for a phase 2 asset within Takeda's Gastrointestinal and Inflammation therapeutic area. Previously Osaze led early R&D business development efforts for Takeda’s GI Inflammation pillar. Osaze completed his medical training at New York University, and holds an MBA from MIT Sloan School of Management, as well as a Bachelor’s in Engineering summa cum laude from Cooper Union.
